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A b s t r A c t
Background: Cancer of the cervix remains an important health problem amongst women worldwide. Widespread comprehensive 
cervical cancer control programs have resulted in a marked reduction in the incidence and mortality in most developed countries. 
Developing countries bear over 80% of the global burden, with only 5% of the global resources for the control of cancer. Majority 
of the cases in these countries present late and are incurable at the time of diagnosis. Aim: To review the presentation and 
histopathological types of cervical cancer cases seen in Aminu Kano Teaching Hospital Kano, over a sixteen‑year period (1995–
2010). Materials and Methods: Case records of histopathologically diagnosed cases of cancer of the cervix were retrieved. 
Demographic data, stage of the tumor at presentation, and histopathologic type were extracted. The results were analyzed 
using descriptive statistics. Results: Six hundred and sixty gynecological cancers were seen during the study period, with cancer 
of the cervix accounting for  58.5% (386/660) cases. Among these cases  with cancer of the cervix 71.1% (275/386) were grand 
multiparous and majority  89.7 % 346/386  presented with advanced disease. Squamous cell carcinoma (SCC) accounted for 86.3% 
(333/386) of the cancers, adenocarcinoma contributed 12.4%,(48/386) and others contributed 1.3% (5/386). Conclusion: Cancer 
of the cervix is the commonest gynecological cancer at Aminu Kano Teaching Hospital, Kano, Nigeria. SCC is the commonest 
histological type.
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InTRODUcTIOn
Cancer of the cervix remains an important health problem 
in women worldwide. It is the second most common cancer 
in women globally and the most frequent in developing 
countries.[1,2]	 Cancer	 of	 the	 cervix	 accounted	 for	 65.7%	 of	
gynecological	 cancers	 in	 Zaria	 and	 63.1%	 of	 gynecological	
cancers in Ilorin, Nigeria.[3,4] Kano is the most populous (10 
million people) state in Nigeria, and has 44 local governments, 
municipal being the biggest with 3.5 million people. Majority 
of the people have low literacy level and some are still averse 
to Western education. A good number of them do not avail 
themselves of any hospital treatment until their disease 
became life threatening. They have an existing sociocultural 
practice of polygamy which predisposes to multiple sexual 
partners and the women tend to have a large number of 
children. Widespread comprehensive cervical cancer control 
programs have resulted in a marked reduction in the incidence 
and mortality in most developed countries where precursor 
lesions which antedate the development of cervical cancer 
by several years are more often detected.[5-8] Women of low 
socioeconomic status and members of ethnic minorities 
who are medically underserved account for the majority of 
the cases in the United States.[5,6] In European countries with 
unevenly implemented screening programs and an aging 
population, the diagnostic rate of cervical cancer is similar 
to estimates for the less developed countries of Africa, and 
Central and South America.[7,8] Worldwide, cervical cancer 
accounts for 500,000 new cases diagnosed and 250,000 
deaths	 every	 year.	Developing	 countries	 bear	 over	 80%	 of	
the	global	burden,	with	only	5%	of	global	resources	for	the	
control of cancer,[1]	 and	 in	 these	 same	 countries,	 75%	 of	
the women present with an advanced disease that may be 
incurable.[1,9]
Amongst the well-characterized risk factors for cancer of 
the cervix, some types of human papilloma virus (HPV) have 
been unequivocally established as causal factors of the 
disease.[2,10,11]	 HPV	 type	 16	 accounts	 for	 50	 to	 60%	 of	 the	
cases in most countries, whereas HPV-18 accounts for 10 
to	12%,	and	HPV‑31	and	45,	4	to	5%	each.[9] Assessments of 
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HPV types in sub-Saharan Africa have shown a higher than 
average proportion of HPV type 45 in addition to the most 
common types 16 and 18.[11] 
HPV is transmitted sexually and the probability of 
transmission is increased with first occurrence of 
sexual intercourse at an early age, multiple sexual 
partners or a consort with multiple sexual partners, 
and an uncircumcised male partner. Cigarette smoking, 
low socioeconomic status, oral contraceptive use, and 
immunosuppression are also factors known to influence 
the risk of cervical cancer positively.[2,12] Epidemiologic 
studies in Nigeria, where cervical cancer is the most 
common female cancer, have demonstrated a link with 
several of the risk factors known to predispose to this 
cancer.[13-15]
Although squamous cell carcinoma (SCC) is the 
predominant histologic type of cervical cancer seen 
globally, recent reports indicate a rising incidence and 
proportion of adenocarcinoma relative to SCC with 
similar epidemiologic risk factors.[16-18] Part of the increase 
has been attributed to an increasing prevalence of HPV 
and partly to the improvement in screening for cervical 
cancer.[19]
In view of the changing trend of histological types of 
cancer of the cervix observed in countries with organized 
population-based cervical screening programs, our study 
attempts to review cases of cervical cancer seen in our 
institution from January 1995 to December 2010, where 
only opportunistic screening exists. 
MATeRIALs AnD MeTHODs
The materials for this study were derived from the folders of 
patients obtained from the Department of Health Records 
and from surgical pathology records in the Department of 
Pathology, Aminu Kano Teaching Hospital Kano, Nigeria, 
over a 16-year period (1995–2010). Kano is the most 
populous (10 million people) state in Nigeria, and has 44 
local governments, municipal being the biggest with 3.5 
million people. The state government has a large general 
hospital (Murtala Muhammad Specialist Hospital) where 
treatment is relatively free. There is no organized screening 
program in the state except occasional opportunistic 
screening by the Medical Women’s Association of Nigeria 
(MWAN). All records of cases of histopathologically 
diagnosed cancer of the cervix were retrieved from the 
medical records department, reviewed, and analyzed for 
age, parity, marital status, presenting complaint, stage 
of the tumor at presentation, and histopathologic type. 
Descriptive statistics methods were used to analyze the 
results as whole numbers, percentages, tables, and charts. 
ResULTs
A total of 660 gynecological cancers were seen during the 
16-year study period with cancer of the cervix accounting 
for	386	cases,	thus	contributing	58.5%	(386/660),	emerging	
as the commonest gynecological cancer in our institution. 
This number may appear small, but most of the women 
with cervical cancer usually go to the state hospital where 
treatment is free.
Figure 1 shows the age distribution of the cancer of the 
cervix with the peak age between 41 and 50 years and it 
demonstrated a bimodal distribution with a major peak in 
the 41–50 year group and a relatively smaller peak in the 
61–70	year	age	group.	About	98.5%	(380/386)	got	married	
in their teens [Table 1].
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Figure 1: Age distribution of patients with cancer of the cervix at AKTH
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patients	 69.5%	 (268/386)	were	married	 [Table	 3].	 About	 a	
third	of	the	patients	(31%)	married	more	than	once	[Figure	2]. 
Only	 12.7%	 (49/386)	 had	 used	 any	 form	of	 contraceptives	
and the type of contraceptive used was distributed equally 
among injectable, intrauterine contraceptive devices 
(IUCDs), and oral contraceptive pills (OCPs).
Two	 hundred	 and	 forty‑seven	 (63.9%)	 247/386	 patients	
presented with vaginal bleeding, offensive vaginal discharge, 
or	both	[Table	4].	Only		18%	(69/386)	of	the	patients	were	
tested	 for	 HIV	 and	 five	 7.3%	 (5/69)	 were	 positive.	 One	
hundred	 and	 sixty‑eight	 (168/386)	 43.5%	 of	 the	 patients	
were	 transfused,	 seven	 (1.9%)	7/386	had	 renal	 failure	 that	
warranted	 dialysis,	 and	 four	 (1%)	 4/386	 had	 vesicovaginal	
fistula	 (VVF)	 and	 rectovaginal	 fistula	 (RVF).	 About	 67%	
(259/386)	of	the	patients	were	referred	for	radiotherapy,	1%	
(4/386)	 had	 total	 abdominal	 hysterectomy	 (TAH),	 and	29%	
(112/386) had palliative treatment. Advanced disease was 





The incidence of invasive cervical cancer has been estimated 
to be on the increase in developing regions of the world, 
notably in Africa, the Caribbean, and Central and South 
America.[1,7,19] Our findings reveal that cervical cancer was 
the most common gynecological cancer during the study 
period	 accounting	 for	 58.5%	 of	 all	 gynecological	 cancers.	
This figure is slightly lower than those of Zaria,[3] Ibadan,[13] 
and Maiduguri.[20] The establishment of opportunistic 
cervical screening services in Kano in 1997 has facilitated 
the detection of preinvasive lesions and even invasive 
cancers which may partly be responsible for the apparent 
lower contribution noted, supporting the potential benefits 
of opportunistic screening.[18] This lends credence to the 
fact that if effective and comprehensive cervical screening 
services are established, we can rest assured that the 
prevalence of cervical cancer would be reduced. The age 
distribution in the present study is similar to the ones 
reported from other studies in Nigeria,[3,20,21] emphasizing the 
fact that cancer of the cervix is a disease of the reproductive 
age group. Bosch et al.[2] have highlighted a bimodal age 
distribution for patients with cancer of the cervix based on 
the observation of some European cancer registries. This 
has also been corroborated by several other investigators 
in agreement with the findings in this study.[15,21,22] The 
second mode has been suggested to be due to the decrease 
in screening coverage and lower sensitivity of cytology in 
older women. The fact that a similar bimodal profile was 
seen in our study in a community with no comprehensive 










AKTH ‑ Aminu Kano Teaching Hospital
Table 1: Age at first marriage among patients with cancer of 
the cervix at AKTH











AKTH ‑ Aminu Kano Teaching Hospital
Table 3: Marital status of patients with cancer of the  
cervix at AKTH
Marital status Frequency %
Divorcee 28 7.3 
Married 268 69.5 
Widow 90 23.2 
Total 386 100.0 
AKTH ‑ Aminu Kano Teaching Hospital
Table 4: Presenting complaints of patients with cervical  
cancer at AKTH
Presenting complaint Frequency %
Lower abdominal pain 17 4.4 
Postcoital bleeding 26 6.7 
Urinary incontinence 8 2.2 
Vaginal bleeding 296 76.7 
Vaginal discharge 39 10.0 
Total 386 100.0 
AKTH ‑ Aminu Kano Teaching Hospital








AKTH ‑ Aminu Kano Teaching Hospital
population-based cervical screening program suggests that 
additional factors may be contributory. Other factors such as 
acquisition of new HPV infections in older women[2] appear 
more convincing, particularly as polygamy is common in 
our society, and divorced or widowed women frequently 
remarry with the possibility of exposure to new strains of 
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HPV[23,24] Our findings however differ with the unique profile 
in developed countries that show an increase after the ages 
of 25–30 years with a plateau after 45–50 years, accounted 
for by effective screening services, whereas developing 
countries are reported to exhibit a linear age distribution.[25]
The demonstration of the association of cancer of the cervix 
with high parity is similar to other findings.[13,14] This could 
be associated with the increased risk of exposure to the 
HPV virus in this group of women.
The commonest symptom at presentation was abnormal 
vaginal	 bleeding	 as	 seen	 in	 63.9%	 of	 cases,	 though	most	
of them had more than one symptom at presentation. 
Similar findings were reported by Oguntayo et al. in Zaria[3] 
and Ijaiya et al. in Ilorin.[4] The high proportion of patients 
presenting	with	late‑stage	disease	(89.7%)	is	similar	to	the	
findings in some other centers.[13,15,16] Similar to the studies 
from Zaria, stage 3 disease was the commonest stage at 
presentation	but	on	the	other	hand,	up	to	10.3%	presented	
with early-stage disease,[3,19] In our study only four women 
presented with stage 1 disease. The diagnosis in one 
woman was confirmed following TAH due to abnormal 
vaginal bleeding, whereas the remaining three had TAH 
because of cervical intraepithelial neoplasia (CIN) 3. The 
other 36 presented with stage 2a disease and all were 
referred for radiotherapy.
Over the years, several attempts have been made to relate 
prognosis of carcinoma of the cervix with histological 
parameters. Majority of the cancers were SCC of the well-
differentiated, large cell keratinizing variety in accordance 
with other local and international studies.[3,9,20,22,23,26,27] There 
was however a relatively large proportion of adenocarcinoma 
(12.4%)	in	comparison	to	earlier	accounts	of	the	disease	in	
Nigerian women,[3,20] but in keeping with the global trend 
of increasing proportion of adenocarcinoma in developed 
countries.[16,22] As this pattern cannot be accounted for by 
opportunistic screening, the likelihood of varying patterns 
of HPV-type prevalence over time (with increasing incidence 
of HPV 18) and exposure to pertinent cofactors require 
consideration.[2,14] Future studies should therefore focus on 
the determination of HPV subtypes in relation to histological 
categories to confirm or refute this suggestion. Amongst 
black women, it has been suggested that increasing age, 
frequent marriages, and high parity raise the probability of 
developing adenocarcinoma of the cervix.[16] These factors 
are known to be prevalent in our environment. Women in 
Nigeria are largely multiparous and as shown in this study, 
this is partly responsible for the high incidence of this 
disease. Women who have seven or more children are at 
double the risk of women with only one or two children.[10] 
Reduction in parity will certainly lead to further decrease in 
the prevalence of cervical cancer.
These findings emphasize the need for the establishment 
of a national organized screening program which at present 
is the most effective preventive intervention that will lead 
to a reduction in the incidence of the disease. Cytology 
screening with the Pap smear has been the mainstay of 
cervical cancer screening for many years, but as knowledge 
of cervical cancer and cervical cancer screening is poor 
in Nigerian women, any organized screening program 
that is established requires to incorporate elements of 
population-based education and personnel training as 
integral components of the screening services, while other 
alternative approaches to screening are being evaluated. 
In addition to effective coverage of the population at risk, 
there should be emphasis on follow-up for appropriate 
treatment.
The introduction of HPV vaccination offers a relevant 
alternative for preventing cervical cancer and is already 
yielding promising results in some developed countries.[21] It 
will however take several decades to become widely available 
in developing countries and the relatively low immunization 
rates for other preventable diseases and shortage of health-
care workers suggest potential challenges for introducing 
such a vaccine. Immunization for HPV requires a huge effort 
and is very costly; the three doses cost approximately $400 
(60,000 N). This cost is prohibitive and unaffordable to the 
Nigerian woman who needs this vaccine. The prevalent 
HPV types in specific geographic regions also need to be 
determined in anticipation for future vaccines that would be 
developed against these HPV types; however, in cytologically 
normal Nigerian women, HPV 35 has been found to be as 
common as the more prevalent HPV 16.[9] In the meantime, 
the bivalent HPV-16/18 virus-like particle vaccine[28] should 
be made more widely available to all regions of the world, 
and together with other ongoing or developing screening 
options, it is hoped that the incidence and mortality related 
to cervical cancer will be brought under control.
Limitations
This was a retrospective study and may not be as powered 
as a prospective one; however, it succeeded in confirming 
that cancer of the cervix is still a major challenge amongst 
women in Africa and still remains so due to lack of 
education and poverty. Patients still present with advanced-
stage disease. Our data was hospital based and only those 
patients who were able to afford the fees came to the 
teaching hospital and not necessarily all those with cervical 
cancer in Kano state. 
cOncLUsIOn
Cancer of the cervix was the commonest gynecological cancer 
in Aminu Kano Teaching Hospital, Kano, Nigeria during the 
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study period and SCC is the commonest histological type. 
An increase in the proportion of adenocarcinoma of the 
cervix was noted.
We recommend the need to establish a rational and 
organized national and local screening program that will 
incorporate elements of population-based education and 
personnel training to reduce the prevalence of cancer of 
the cervix in our community.
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